Search results for "Glucose tolerance test"

showing 10 items of 74 documents

Oleanolic acid improves diet-induced obesity by modulating fat preference and inflammation in mice.

2018

Obesity, triggered by high-fat diet (HFD), is associated to altered gustatory perception of dietary lipids. Oleanolic acid (OLA), a triterpene, has been reported to exert anti-obesity effects in animal models. Hence, we investigated the role of OLA in the modulation of oro-sensory perception of lipids in control and HFD-induced obese mice. As expected, OLA-treated obese mice exhibited a decrease in body, liver, and visceral adipose tissue weights. OLA treatment improved glucose tolerance, insulin level, plasma lipopolysaccharide (LPS), and hepatic cholesterol and triglyceride concentrations. OLA-treated obese mice exhibited higher fat preference compared to untreated obese mice, probably du…

0301 basic medicineCD36 AntigensLipopolysaccharidesmedicine.medical_specialtyCD36medicine.medical_treatmentInterleukin-1betaAdipose tissue030209 endocrinology & metabolismInflammationDiet High-FatDiet MediterraneanWeight GainBiochemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicineTaste receptorInternal medicinemedicineAnimalsInsulinObesityRNA MessengerOleanolic AcidCarbohydrate-responsive element-binding proteinOleanolic acidInflammationbiologyTriglycerideChemistryInterleukin-6InsulinLipogenesisGeneral MedicineGlucose Tolerance TestTaste BudsMice Inbred C57BL030104 developmental biologyEndocrinologyAdipose TissueLiverbiology.proteinCalciumFemalemedicine.symptomInflammation MediatorsBiochimie
researchProduct

Histone macroH2A1.2 promotes metabolic health and leanness by inhibiting adipogenesis

2016

Background Obesity has tremendous impact on the health systems. Its epigenetic bases are unclear. MacroH2A1 is a variant of histone H2A, present in two alternatively exon-spliced isoforms macroH2A1.1 and macroH2A1.2, regulating cell plasticity and proliferation, during pluripotency and tumorigenesis. Their role in adipose tissue plasticity is unknown. Results Here, we show evidence that macroH2A1.1 protein levels in the visceral adipose tissue of obese humans positively correlate with BMI, while macroH2A1.2 is nearly absent. We thus introduced a constitutive GFP-tagged transgene for macroH2A1.2 in mice, and we characterized their metabolic health upon being fed a standard chow diet or a hig…

0301 basic medicineGenetically modified mouseCyclin-Dependent Kinase Inhibitor p21macroh2a1.2TransgeneAdipose tissueAdipose tissueMice TransgenicBiologyCarbohydrate metabolismDiet High-FatBody Mass IndexCell LineHistones03 medical and health sciencesMiceHistone variantGeneticsAnimalsHumansInsulinEpigeneticsAdipose tissue Histone variants Obesity macroh2a1.2ObesityTranscription factorPancreasMolecular BiologyUncoupling Protein 1SkinHistone variantsAdipogenesisResearchCell DifferentiationGlucose Tolerance TestMolecular biologyCell biologyMice Inbred C57BL030104 developmental biologyPhenotypeLiverMetabolic EngineeringAdipogenesisDNA methylationAdipose tissue; Histone variants; macroh2a1.2; Obesity; Molecular Biology; Genetics
researchProduct

Circulating Irisin Levels in Children With GH Deficiency Before and After 1 Year of GH Treatment.

2018

Abstract Purpose To evaluate circulating irisin levels in children with GH deficiency (GHD) and any relation with clinical and metabolic parameters. Patients Fifty-four prepubertal children (mean age, 7.4 ± 0.8 years) with idiopathic GHD treated with GH for at least 12 months and 31 healthy short children as control subjects. Methods Body height, body mass index (BMI), waist circumference (WC), IGF-I, HbA1c, lipid profile, fasting and after–oral glucose tolerance test glucose and insulin, insulin sensitivity indices, and irisin levels were evaluated at baseline and after 12 months of GH replacement (GHR). Results At baseline, children with GHD, in addition to having lower growth velocity (P…

0301 basic medicineMalemedicine.medical_specialtyWaistHormone Replacement TherapyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentClinical Biochemistry030209 endocrinology & metabolismGrowth hormone receptorBiochemistrySettore MED/13 - EndocrinologiaGrowth hormone deficiencyBody Mass Index03 medical and health sciences0302 clinical medicineEndocrinologyInsulin resistanceInternal medicinemedicineHumansProspective StudiesInsulin-Like Growth Factor IChildGrowth DisordersGlucose tolerance testmedicine.diagnostic_testbusiness.industryInsulinBiochemistry (medical)medicine.diseaseFibronectins030104 developmental biologyEndocrinologyTreatment OutcomeGrowth HormoneFemaleWaist CircumferenceLipid profilebusinessBody mass indexThe Journal of clinical endocrinology and metabolism
researchProduct

Decreases in Circulating Concentrations of Long-Chain Acylcarnitines and Free Fatty Acids During the Glucose Tolerance Test Represent Tissue-Specific…

2019

Background: Insulin plays a pivotal role in the regulation of both carbohydrate and lipid intermediate turnover and metabolism. In the transition from a fasted to fed state, insulin action inhibits lipolysis in adipocytes, and acylcarnitine synthesis in the muscles and heart. The aim of this study was to measure free fatty acid (FFA) and acylcarnitine levels during the glucose tolerance test as indicators of tissue-specific insulin resistance. Results: Insulin release in response to glucose administration decreased both FFA and long-chain acylcarnitine levels in plasma in healthy control animals by 30% (120 min). The glucose tolerance test and [3H]-deoxy-D-glucose uptake in tissues revealed…

0301 basic medicinemedicine.medical_specialtyGlucose uptakemedicine.medical_treatmentEndocrinology Diabetes and MetabolismAdipose tissuelong-chain acylcarnitines030209 endocrinology & metabolismType 2 diabetesglucose tolerance testlcsh:Diseases of the endocrine glands. Clinical endocrinology03 medical and health sciences0302 clinical medicineInsulin resistanceEndocrinologyInternal medicineinsulin resistancemedicineLipolysisOriginal ResearchGlucose tolerance testlcsh:RC648-665medicine.diagnostic_testChemistryInsulinfree fatty acidsmedicine.disease030104 developmental biologyEndocrinologyPostprandialtype 2 diabetesFrontiers in Endocrinology
researchProduct

Red cell sorbitol concentration in relation to short- and medium-term variation of plasma glucose.

1989

To evaluate the time course of changes in red cell sorbitol (RCS) concentration in relation to variations of plasma glucose levels, RCS was determined in 7 normal subjects during i.v. glucose infusion (IVGTT); in 6 hyperglycemic insulin-dependent diabetic subjects while glycemia was normalized with Biostator GC 115 and in 4 diabetic patients in previously poor metabolic control, in whom normal glycemia was obtained in 8–10 days by intensive insulin therapy. During IVGTT, plasma glucose levels increased with significant differences from baseline at 5, 10, 16, 25, 60, 100 and 160 min and returned to basal levels after 3h; RCS concentration showed small and insignificant increases. During i.v.…

Activity CyclesBlood GlucoseMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentmacromolecular substancesMedium termchemistry.chemical_compoundEndocrinologyReference ValuesInternal medicineDiabetes mellitusInternal MedicinemedicineHumansSorbitolPlasma glucoseRed Cellbusiness.industryInsulinGeneral MedicineGlucose Tolerance TestMiddle Agedmedicine.diseaseCircadian RhythmEndocrinologyDiabetes Mellitus Type 1GlucoseBasal (medicine)chemistryMetabolic control analysisHyperglycemiaSorbitolbusinessActa diabetologica latina
researchProduct

Treatment results of acromegaly as analyzed by different criteria.

1997

Results of treatment of acromegaly are often incomparable due to the different criteria which have been used for defining cure or control of disease. At the present time it is widely accepted, that the main criteria of cure must be normalization of IGF-1 and a GH in the OGTT2 ng/ml. In this retrospective study we investigated the endocrinological results of 56 patients, who were surgically treated because of a GH-producing pituitary adenoma, by different criteria. Twelve of our patients had had additional medical treatment after surgery, two received radiotherapy. At a mean follow-up of 34 months after surgery 66% of patients had a basal GH5 ng/ml, 64% had a GH in the OGTT2 ng/ml and 73% ha…

AdenomaAdultMalemedicine.medical_specialtyAdenomamedicine.medical_treatmentHypopituitarismHypopituitarismPituitary adenomaAcromegalymedicineHumansPituitary NeoplasmsInsulin-Like Growth Factor IAgedTranssphenoidal surgerymedicine.diagnostic_testbusiness.industryHuman Growth HormoneRetrospective cohort studyInterventional radiologyGlucose Tolerance TestMiddle Agedmedicine.diseaseSurgeryAcromegalySurgeryFemaleNeurology (clinical)NeurosurgerybusinessFollow-Up StudiesActa neurochirurgica
researchProduct

Improved usability of the minimal model of insulin sensitivity based on an automated approach and genetic algorithms for parameter estimation.

2006

Minimal model analysis of glucose and insulin data from an IVGTT (intravenous glucose tolerance test) is widely used to estimate insulin sensitivity; however, the use of the model often requires intervention by a trained operator and some problems can occur in the estimation of model parameters. In the present study, a new method for minimal model analysis, termed GAMMOD, was developed based on genetic algorithms for the estimation of model parameters. Such an algorithm does not require the fixing of initial values for the parameters (that may lead to unreliable estimates). Our method also implements an automated weighting scheme not requiring manual intervention of the operator, thus impro…

AdultBlood GlucoseComputer scienceEstimation theorybusiness.industryDecision treeEvolutionary algorithmReproducibility of ResultsContext (language use)UsabilityGeneral MedicineGlucose Tolerance TestModels BiologicalWeightingMinimal modelDiabetes GestationalPregnancyGenetic algorithmHumansInsulinFemaleInsulin ResistancebusinessAlgorithmAlgorithmsClinical science (London, England : 1979)
researchProduct

The pancreatic beta-cell response to intravenous administration of glucose in elderly subjects.

1970

A study was made of the serum insulin level after the intravenous administration of glucose (0.33 gm/ kg) in two groups of normal subjects—18 in the 60–85 age bracket, and 16 in the 23–45 age bracket. All had a normal coefficient of glucose utilization and a normal blood glucose curve after intravenous administration of glucose. Serum insulin was assayed by the radio-immunological method, with use of an ion exchange resin. Blood samples were drawn at 2, 5, 10, 30, 45 and 60 minutes after the end of the glucose infusion. In the elderly subjects the maximal value was reached only after 5 minutes and the mean value was 39± 9 µU/ml (range, 27–50), whereas in the younger subjects the serum insul…

AdultBlood GlucoseGlucose utilizationmedicine.medical_specialtymedicine.medical_treatmentRadioimmunoassayStimulationGlucose infusionInternal medicineMedicineHumansInsulinPancreasAgedbusiness.industryInsulinMean valueAge FactorsGlucose Tolerance TestMiddle AgedPeripheralEndocrinologyGlucoseInjections IntravenousGeriatrics and GerontologyBeta cellbusinessNormal blood glucoseJournal of the American Geriatrics Society
researchProduct

Erratum: Effect of magnesium supplementation on glucose metabolism in people with or at risk of diabetes: a systematic review and meta-analysis of do…

2016

Although higher dietary intakes of magnesium (Mg) seem to correspond to lower diabetes incidence, research concerning Mg supplementation in people with or at risk of diabetes is limited. Thus, we aimed to investigate the effect of oral Mg supplementation on glucose and insulin-sensitivity parameters in participants with diabetes or at high risk of diabetes compared with placebo. A literature search in PubMed, EMBASE, SCOPUS, Cochrane Central Register of Controlled Trials and Clinicaltrials.gov without language restriction, was undertaken. Eligible studies were randomized controlled trials (RCTs) investigating the effect of oral Mg supplementation vs placebo in patients with diabetes or at h…

AdultBlood GlucoseMale0301 basic medicinemedicine.medical_specialtyCalorieMagnesium supplementationMedicine (miscellaneous)030209 endocrinology & metabolismCarbohydrate metabolismlaw.inventionDouble blind03 medical and health sciences0302 clinical medicineDouble-Blind MethodRandomized controlled triallawInternal medicineDiabetes mellitusDiabetes MellitusmedicineHumansMagnesiumAgedRandomized Controlled Trials as TopicGlucose tolerance test030109 nutrition & dieteticsNutrition and Dieteticsmedicine.diagnostic_testbusiness.industryMedicine (all)Medicine (miscellaneous); Medicine (all); Nutrition and DieteticsFastingGlucose Tolerance TestMiddle Agedmedicine.diseaseObesityEndocrinologyMeta-analysisDietary Supplementsmagnesium Nutrition diabetes Dietetics glucose metabolismFemalebusinessBody mass indexEuropean Journal of Clinical Nutrition
researchProduct

The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.

2004

Aim The objective behind the Euro Heart Survey on diabetes and the heart was to study the prevalence of abnormal glucose regulation in adult patients with coronary artery disease (CAD). Methods and results The survey engaged 110 centres in 25 countries recruiting 4196 patients referred to a cardiologist due to CAD out of whom 2107 were admitted on an acute basis and 2854 had an elective consultation. Patient data were collected via a web-based case record form. An oral glucose tolerance test (OGTT) was used for the characterisation of the glucose metabolism. Thirty-one per cent of the patients had diabetes. An OGTT was performed on the 1920 patients without known diabetes, of whom 923 had a…

AdultBlood GlucoseMaleDiabetes mellitumedicine.medical_specialtyAbnormal glucoseDiabetic AngiopathieOral glucose tolerance testCoronary Artery DiseaseImpaired glucose toleranceCoronary artery diseaseSDG 3 - Good Health and Well-beingRisk FactorsDiabetes mellitusInternal medicineEpidemiologymedicineHumansIn patientAgedGlucose tolerance testmedicine.diagnostic_testbusiness.industryImpaired glucose toleranceGlucose Tolerance TestMiddle Agedmedicine.diseaseSurgeryEuropeDiabetes Mellitus Type 2Blood sugar regulationFemaleCardiology and Cardiovascular MedicinebusinessDiabetic AngiopathiesHumanEuropean heart journal
researchProduct